Prescribed List Reforms - Consultation Paper 9 - CIEDs and the cost of technical support services

Overview

On 19 April 2024, stakeholders were provided with an update on the Technical support services component of the CIED PL benefit. This included the Medical Services Advisory Committee (MSAC) advice and associated public summary document.

We are inviting stakeholders to provide views, suggestions, and ideas on how to implement the MSAC advice about the cost of technical support services (TSS) for cardiac implantable electronic devices (CIEDs). We ask that you raise any matters of concern or negative implications for your organisation, you and/or your sector.

We acknowledge the impact that amendments to the current funding model for these services could have on consumers, sponsors, technicians and public and private hospitals and as such we are interested in understanding all perspectives on this matter.

Your feedback will be used to inform further stakeholder engagement as well as the development of options for implementation of the MSAC advice.

Why your views matter

We want to hear from all stakeholders to develop informed options to implement the MSAC advice and reduce the risk of unintended consequences.

We ask that stakeholders provide suggestions, views and ideas, raise matters of concern or negative implications for your organisation, you and/or your sector. Please read Consultation Paper 9, consider the questions, and provide your responses including as much detail and evidence as possible about the impacts as well as any options for consideration.